Evidence map›Paper›PMID 36001295›Full record

ArticleJournal of nephrology2023

Negative prognostic impact of electrolyte disorders in patients hospitalized for Covid-19 in a large multicenter study.

Simonetta Genovesi, Giuseppe Regolisti, Paola Rebora, Giuseppe Occhino, Michele Belli, Giulio Molon, Giuseppe Citerio, Anna Beltrame, Alessandro Maloberti, Elena Generali and 7 more

Open access · bronzeAbstract readMulticenter StudyLetter
In one paragraph

Article in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

Simonetta GenovesiSchool of Medicine and Surgery, Nephrology Clinic, Milano-Bicocca University, Milan, Italy. simonetta.genovesi@unimib.it.ORCID http://orcid.org/0000-0002-4699-4149
Giuseppe RegolistiClinica e Immunologia Medica, Azienda Ospedaliero-Universitaria, Parma, Italy.
Paola ReboraBicocca Bioinformatics Biostatistics and Bioimaging Centre, School of Medicine and Surgery Milano-Bicocca University, Milan, Italy.
Giuseppe OcchinoBicocca Bioinformatics Biostatistics and Bioimaging Centre, School of Medicine and Surgery Milano-Bicocca University, Milan, Italy.
Michele BelliSchool of Medicine and Surgery, Nephrology Clinic, Milano-Bicocca University, Milan, Italy.
Giulio MolonCardiology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Giuseppe CiterioSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Anna BeltrameDepartment of Infectious/Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Alessandro MalobertiSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Elena GeneraliDepartment of Biomedical Sciences, Humanitas University, Emanuele, Italy.
Cristina GiannattasioSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Oscar Massimiliano EpisDivision of Rheumatology, Multispecialist Medical Department, Niguarda Hospital, Milan, Italy.
Claudio RossettiDepartment of Training and Research, Niguarda Hospital, Milan, Italy.
Giuseppe BellelliSchool of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Ana Lleo De NaldaDepartment of Biomedical Sciences, Humanitas University, Emanuele, Italy.
Ilaria CapuaOne Health Center of Excellence, University of Florida, Gainesville, FL, 32611, USA.
Maria Grazia ValsecchiBicocca Bioinformatics Biostatistics and Bioimaging Centre, School of Medicine and Surgery Milano-Bicocca University, Milan, Italy.
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITUniversity of Milano-Bicocca · ITHumanitas University · ITOspedale Sacro Cuore Don Calabria · ITASST Melegnano e della Martesana · ITAzienda Ospedaliera San Gerardo · ITIRCCS Istituto Auxologico Italiano · ITUniversity of Florida Health · USUniversity of Parma · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca 2017-NAZ-446Ministero dell'Istruzione, dell'Università e della Ricerca MGVMinistero dell'Istruzione, dell'Università e della Ricerca PRIN 0178S4EK9
6 · The paper itself

Abstract

backgroundThe prognostic impact of electrolyte disorders in hospitalized COVID-19 patients is unclear.

methodsThe study included all adult patients hospitalized for COVID-19 in four hospitals in Northern Italy between January 2020 and May 2021 with at least one serum potassium and sodium measurement performed within 3 days since admission. Primary outcome was in-hospital death; secondary outcome was Intensive Care Unit (ICU) admission. A cause-specific Cox proportional-hazards regression model was used for investigating the association between potassium and sodium (as either categorical or continuous variables) and mortality or admission to ICU.

resultsAnalyses included 3,418 adult hospitalized COVID-19 patients. At multivariable analysis, both hyperkalemia (Hazard Ratio, [HR] 1.833, 95% Confidence Interval [CI] 1.371-2.450) and sK above the median (K 5.1 vs 4.1 mmol/L: HR 1.523, 95% CI 1.295-1.798), and hypernatremia (HR 2.313, 95%CI 1.772-3.018) and sNa above the median (Na 149 vs 139 mmol/L: HR 1.442, 95% CI 1.234-1.686), were associated with in-hospital death, whereas hypokalemia and hyponatremia were not. Hyponatremia was associated with increased hazard of ICU admission (HR 1.884, 95%CI 1.389-2.556).

conclusionsElectrolyte disorders detected at hospital admission may allow early identification of COVID-19 patients at increased risk of adverse outcomes.

Indexed as

COVID-19HyponatremiaAdultElectrolytesHospital MortalityHumansPotassiumPrognosisSodiumElectrolytesPotassiumSodiumCOVID-19ElectrolytesIntensive care unitsMortalityPotassiumSodium

Identifiers

PMID36001295
PMCPMC9400003
OpenAlexW4293180179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.